CDKN2A and metastatic neoplasm: In Patient 3, three genomic loci—9p21 (CDKN2A and MTAP), 11q13 (OVOL1), and 11p15 (HRAS)—were homozygously deleted in the primary site tumor population (3PST) but not in the metastatic tumor population (3MT).